Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, announces the completion of its previously announced acquisition of Rendiatech, Inc., an Israeli-based developer of automated kidney function monitoring technology designed to support clinical decision-making in critically ill patients. Rendiatech has no commercial operations and was formed to acquire certain assets of RenalSense Ltd. following its bankruptcy proceedings; the Company purchased Rendiatech primarily to gain access to such assets.
Read the full article: Nuwellis Completes Acquisition of Rendiatech //
Source: https://www.globenewswire.com/news-release/2026/03/17/3257096/26106/en/Nuwellis-Completes-Acquisition-of-Rendiatech.html